Methocarbamol is a central muscle relaxant used to treat skeletal muscle spasms. Under the trade name Robaxin it is marketed by Actient Pharmaceuticals in the United States and Pfizer in Canada. Methocarbamol produces its clinical effects through agonism of the GABAA receptor resulting in an exaggerated effect of gamma-aminobutyric acid (GABA) which occurs naturally in the brain.
This page contains content from the copyrighted Wikipedia article "Methocarbamol"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
